[MYX] YoY Quarter Result on 30-Jun-2022 [#Q4]

Stock
[MYX] Mayne Pharma Group Limited
Announcement Date
29-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q4]
Profit Trend
QoQ- -322.82%
YoY- -684.81%
Quarter Report
MYX's Result
MYX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 200,473 82,421 228,362 191,939 229,833 250,837 287,057 -5.80%
PBT -115,222 -103,161 -154,116 -34,632 -110,407 -365,597 44,056 -
Tax -17,152 85,107 69,237 -7,229 -34,480 -80,845 5,177 -
NP -103,681 -171,844 -212,973 -27,137 -75,246 -283,446 40,222 -
Tax Rate - - - - - - -11.75% -
Total Cost 304,154 254,265 441,335 219,076 305,079 534,283 246,835 3.53%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -51.72 -208.50 -93.26 -14.14 -32.74 -113.00 14.01 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -1.28 -2.06 -2.41 -0.31 -0.90 -3.43 0.55 -
EPS Diluted -1.31 -2.06 -2.41 -0.31 -0.90 -3.41 0.55 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.